Efficacy of Healing Touch in Stressed Neonates
1 other identifier
interventional
13
1 country
1
Brief Summary
The purpose of this project is to evaluate whether or not Healing Touch therapy (HT) helps to treat the stress of babies in the Neonatal Intensive Care Unit (NICU). Healing Touch is a gentle use of human touch - a light, soft placement without moving of the HT therapist's hand on a baby's body - and energy to create balance and relaxation. The goal of HT treatment is to help babies rest better, have less pain and discomfort and to heal more quickly. Healing Touch works along with all the treatments and medicines babies receive as part of ordinary care in the NICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jul 2003
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2002
CompletedFirst Posted
Study publicly available on registry
April 22, 2002
CompletedStudy Start
First participant enrolled
July 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2004
CompletedAugust 18, 2006
July 1, 2006
April 19, 2002
August 17, 2006
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Enrollment upon admission to the NICU and up to 7 days after admission
- Admission to the NICU requiring Level III care during the study period (7 days).
- Infants requiring ventilator support within the first 48 hours after admission.
- Infants requiring tube feedings \> 50% of the time at the time of study entry.
- Both term and preterm infants (Any neonate admitted to the NICU - 20+ weeks gestation to term or more.)
You may not qualify if:
- All infants with cyanotic congenital heart disease.
- Other major congenital anomalies requiring immediate surgery.
- Infants admitted for a period predicted to be significantly less than 7 days; if status changes, the infant may be entered at that time.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Arizona, University Medical Center, Neonatal Intensive Care Unit
Tucson, Arizona, 85724, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon I. McDonough-Means, MD
University of Arizona, College of Medicine, Program in Integrative Medicine and Dept. of Pediatrics
Iris R. Bell, MD, PhD
University of Arizona, Department of Psychiatry and Program in Integrative Medicine, College of Medicine
Rosemarie Bigsbury, ScD, OTR/L
Infant Development Center, Department of Pediatrics, Women & Infants' Hospital, Brown University School of Medicine
Jane Doussard-Roosevelt, PhD
Department of Human Development, University of Maryland
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 19, 2002
First Posted
April 22, 2002
Study Start
July 1, 2003
Study Completion
July 1, 2004
Last Updated
August 18, 2006
Record last verified: 2006-07